BMO Capital analyst Andrew Strelzik maintains Dave & Buster’s Enter (NASDAQ:PLAY) with a Outperform and raises the price target from $62 to $66.
Treace Announces Grant Of U.S. Patent And Allowance Of U.S. Patent Application On Bone Positioner Technology For Bunion Correction
Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NASDAQ:TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of hallux valgus
